-
What the National Institute on Drug Abuse’s Clinical Trials Network can do for you? Major findings from medication trials and implications for community-based settings.
Weiss RD. What the National Institute on Drug Abuse's Clinical Trials Network can do for you? Major findings from medication trials and implications for community-based settings. Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
-
Community providers’ impression of HIV prevention intervention research in NIDA’s Clinical Trials Network.
Campbell ANC, Hartzler B, Hatch-Maillette MA, Calsyn DA, Miele GM, Tross S. Community providers' impression of HIV prevention intervention research in NIDA's Clinical Trials Network. Journal of Drug Issues 2011;41(4):441-460.
-
Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma study: Implications for posttrial implementation.
Pinto RM, Campbell ANC, Hien DA, Yu G, Gorroochurn P. Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma study: Implications for posttrial implementation. American Journal of Orthopsychiatry 2011;81(2):211-217.
-
Ten take home lessons from the first 10 Years of the CTN and 10 recommendations for the future.
Carroll KM, Ball SA, Jackson TR, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD. Ten take home lessons from the first 10 Years of the CTN and 10 recommendations for the future. American Journal of Drug and Alcohol Abuse 2011;37(5):275-282.
-
Addicted to discovery: Does the quest for new knowledge hinder practice improvement?
Perl HI. Addicted to discovery: Does the quest for new knowledge hinder practice improvement? Addictive Behaviors 2011;36(6):590-596.
-
HIV rapid testing in substance abuse treatment: Implementation following a clinical trial.
Haynes LF, Korte JE, Holmes BW, Gooden LK, Matheson T, Feaster DJ, Leff JA, Wilson L, Metsch LR, Schackman BR. HIV rapid testing in substance abuse treatment: Implementation following a clinical trial. Evaluation and Program Planning 2011;34(4):399-406.
-
Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation.
Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation. Addictive Behaviors 2011;36(6):584-589.
-
Counselors’ knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.
Rothrauff TC, Eby LT. Counselors’ knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. American Journal on Addictions 2010;20(1):56-62
-
Implementing an adapted version of the Job Seekers’ Workshop in a residential program for patients with substance use disorders.
Hamdi NR, Levy MS, Jaffee WB, Chisholm SM, Weiss RD. Implementing an adapted version of the Job Seekers' Workshop in a residential program for patients with substance use disorders. Journal of Addiction Medicine 2011;5(2):148-152.
-
NIDA Clinical Trials Network: Examples of community program buprenorphine dissemination in low-access areas.
Connery HS, Publicker M, Hoyne J, Cohan A, Provost SE, Woody GE, Weiss RD. NIDA Clinical Trials Network: Examples of Community Program Buprenorphine Dissemination in Low-Access Areas. Poster presented at the American Academy of Addiction Psychiatry annual meeting, Boca Raton, FL, December 2-5, 2010